Merkel Cell Carcinoma

 

Interleukin-12 by Electroporation for Merkel Cell Carcinoma
A Phase II Study of Intratumoral Injection of Interleukin-12 Plasmid and in Vivo Electroporation in Patients With Merkel Cell Carcinoma

Investigator: Shailender Bhatia, M.D.;   Conditions: Merkel Cell Carcinoma;    Status: Recruiting;   Study ID: NCT01440816